Discounted Cash Flow (DCF) Analysis Unlevered

Dolby Laboratories, Inc. (DLB)

$83.36

+0.75 (+0.91%)
All numbers are in Millions, Currency in USD
Stock DCF: 44.30 | 83.36 | overvalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 1,171.921,241.621,161.791,281.261,253.791,277.791,302.251,327.181,352.591,378.48
Revenue (%)
EBITDA 393.79367.25330.52460.15319.47391.07398.55406.18413.96421.88
EBITDA (%)
EBIT 312.51282.12239.65347.39215.86292.22297.81303.52309.33315.25
EBIT (%)
Depreciation 81.2885.1290.88112.76103.6198.85100.74102.67104.63106.63
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 1,096.20916.361,118.821,264.22809.341,090.891,111.771,133.061,154.751,176.85
Total Cash (%)
Account Receivables 139.59385.55341.70414.92419.69353.26360.03366.92373.94381.10
Account Receivables (%)
Inventories 26.2132.3325.5510.9723.5524.9825.4525.9426.4426.94
Inventories (%)
Accounts Payable 21.9215.2112.6217.7814.1717.1217.4517.7818.1218.47
Accounts Payable (%)
Capital Expenditure -85.36-113.54-68.99-54.45-59.46-80.14-81.67-83.24-84.83-86.45
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 83.36
Beta 1.005
Diluted Shares Outstanding 101.98
Cost of Debt
Tax Rate 14.49
After-tax Cost of Debt 0.66%
Risk-Free Rate
Market Risk Premium
Cost of Equity 8.348
Total Debt 50.94
Total Equity 8,501.30
Total Capital 8,552.24
Debt Weighting 0.60
Equity Weighting 99.40
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 1,171.921,241.621,161.791,281.261,253.791,277.791,302.251,327.181,352.591,378.48
EBITDA 393.79367.25330.52460.15319.47391.07398.55406.18413.96421.88
EBIT 312.51282.12239.65347.39215.86292.22297.81303.52309.33315.25
Tax Rate 60.93%9.62%3.48%12.49%14.49%20.20%20.20%20.20%20.20%20.20%
EBIAT 122.10254.98231.30304184.59233.19237.65242.20246.83251.56
Depreciation 81.2885.1290.88112.76103.6198.85100.74102.67104.63106.63
Accounts Receivable --245.9643.85-73.23-4.7666.42-6.76-6.89-7.02-7.16
Inventories --6.136.7814.59-12.58-1.43-0.48-0.49-0.50-0.51
Accounts Payable --6.71-2.605.16-3.612.950.330.330.340.35
Capital Expenditure -85.36-113.54-68.99-54.45-59.46-80.14-81.67-83.24-84.83-86.45
UFCF 118.03-32.23301.22308.82207.79319.84249.80254.58259.46264.42
WACC
PV UFCF 295.33212.98200.42188.60177.48
SUM PV UFCF 1,074.82

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 8.30
Free cash flow (t + 1) 269.71
Terminal Value 4,281.15
Present Value of Terminal Value 2,873.55

Intrinsic Value

Enterprise Value 3,948.36
Net Debt -569.18
Equity Value 4,517.55
Shares Outstanding 101.98
Equity Value Per Share 44.30